Inspire Medical Systems Past Earnings Performance
Past criteria checks 0/6
Inspire Medical Systems's earnings have been declining at an average annual rate of -3.5%, while the Medical Equipment industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 47.9% per year.
Key information
-3.5%
Earnings growth rate
2.9%
EPS growth rate
| Medical Equipment Industry Growth | 4.3% |
| Revenue growth rate | 47.9% |
| Return on equity | -3.7% |
| Net Margin | -3.4% |
| Next Earnings Update | 07 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Inspire Medical Systems makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 625 | -21 | 452 | 117 |
| 30 Sep 23 | 570 | -33 | 423 | 107 |
| 30 Jun 23 | 526 | -41 | 395 | 99 |
| 31 Mar 23 | 466 | -44 | 359 | 82 |
| 31 Dec 22 | 408 | -45 | 321 | 69 |
| 30 Sep 22 | 348 | -50 | 285 | 58 |
| 30 Jun 22 | 301 | -44 | 252 | 46 |
| 31 Mar 22 | 262 | -43 | 224 | 41 |
| 31 Dec 21 | 233 | -42 | 203 | 37 |
| 30 Sep 21 | 201 | -47 | 182 | 34 |
| 30 Jun 21 | 175 | -47 | 162 | 32 |
| 31 Mar 21 | 134 | -57 | 141 | 29 |
| 31 Dec 20 | 115 | -57 | 128 | 26 |
| 30 Sep 20 | 96 | -59 | 117 | 23 |
| 30 Jun 20 | 81 | -57 | 107 | 19 |
| 31 Mar 20 | 87 | -41 | 100 | 16 |
| 31 Dec 19 | 82 | -33 | 90 | 13 |
| 30 Sep 19 | 72 | -29 | 78 | 11 |
| 30 Jun 19 | 64 | -25 | 69 | 9 |
| 31 Mar 19 | 57 | -24 | 62 | 8 |
| 31 Dec 18 | 51 | -22 | 54 | 7 |
| 30 Sep 18 | 44 | -21 | 48 | 7 |
| 30 Jun 18 | 38 | -21 | 42 | 6 |
| 31 Mar 18 | 33 | -20 | 37 | 6 |
| 31 Dec 17 | 29 | -18 | 32 | 6 |
| 31 Dec 16 | 16 | -19 | 23 | 7 |
| 31 Dec 15 | 8 | -21 | 18 | 7 |
Quality Earnings: 2DR is currently unprofitable.
Growing Profit Margin: 2DR is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 2DR is unprofitable, and losses have increased over the past 5 years at a rate of 3.5% per year.
Accelerating Growth: Unable to compare 2DR's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 2DR is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-9.8%).
Return on Equity
High ROE: 2DR has a negative Return on Equity (-3.69%), as it is currently unprofitable.